Forensic Analysis of Foreign Particles in Pharmaceutical Materials at the IFPAC Annual Meeting
Gateway Analytical is proud to announce...
As seen in Inhalation Magazine – Our article discussing the application of SEM-EDS for inhalable drug products
This article provides an introduction...
AAFS 2013 Presentation: What Judges and Lawyers Need to Know about the Science Behind Trace Evidence
Authors & ContributorsCara PleseAntonio Scatena
Gateway Analytical Growth Demands Move to a Larger Facility
Gateway Analytical announced today that the...
Monitoring Degree of Agglomeration in Aqueous Suspensions Subjected to Various Environmental Conditions by Raman Imaging
Outsourcing the development and manufacturing...
2018 PDA Annual Meeting: A Proactive Approach to the Particulate Management Lifecycle in Parenteral Drug Products
Authors & ContributorsDavid Exline, Cara Plese
Gateway Analytical Receives ISO 17025:2005 Accreditation from the American Association for Laboratory Accreditation
PITTSBURGH, PA – Gateway Analytical announced...
2014 ASSA International IWPCPS-16 Workshops: Spatially-Resolved Raman Imaging for Ingredient-Specific Characterization of Combination Dry Powder Inhalers
June 17, 2014 Since the approval of Dry Powder Inhalers containing Fluticasone Propionate and Salmeterol Xinafoate in 1999, combination inhaled therapies have dominated the COPD market. However, due to the lack of specific guidance of the Office of Generic Drugs as to the abbreviated new drug application submission, there was…
Shedding Light on the Utility of FTIR vs. Raman Spectroscopy
Read Gateway Analytical's piece on shedding light on the utility of FTIR vs. Raman spectroscopy.